Nilsen Per, Kirk Jeanette Wassar, Gunnarsson Katarina Ulfsdotter, Thomas Kristin
Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden.
Faculty of Medicine and Health Sciences, Halmstad University, Halmstad, Sweden.
Implement Sci Commun. 2025 Aug 23;6(1):90. doi: 10.1186/s43058-025-00781-2.
The distinction between efficacy (performance under ideal conditions) and effectiveness (performance in real-world settings) is well established in intervention research. Intervention effectiveness is often used as a proxy for implementation readiness. However, relying on this assumption can lead to overly optimistic expectations about real-world outcomes if the complexities of routine practice settings are not adequately considered.
This paper introduces the distinction between implementation efficacy (implementation strategy performance under controlled or highly supported conditions) and implementation effectiveness (performance under typical, resource-constrained settings). We argue that the efficacy-effectiveness distinction is as critical for implementation research as it is for intervention research. Recognizing and systematically operationalizing this distinction can sharpen conceptual clarity, strengthen research design and enhance the relevance and generalizability of findings for real-world application. Yet despite its importance, this distinction is rarely made explicit in implementation studies. Research often fails to specify the conditions under which implementation strategies are investigated; studies can vary widely in how closely they reflect routine practice. Compounding this issue, economic evaluations remain uncommon in implementation research. However, without systematic assessment of resource use, it is difficult to determine whether reported implementation outcomes have been achieved through contextually feasible strategies or through intensive supports, such as dedicated staffing, external facilitation, or financial incentives, which are rarely available in everyday practice. To address this gap, we propose adapting the PRECIS-2 (Pragmatic Explanatory Continuum Indicator Summary 2) framework from clinical trials into an "Implementation PRECIS" tool. An adapted version of PRECIS-2 for implementation research could offer a systematic way to describe the extent to which a study reflects idealized conditions versus real-world practice.
Clarifying whether implementation strategies are studied under efficacy-like or effectiveness-like conditions enhances research design, interpretation, and communication with stakeholders. It also supports informed decisions about replication and scale-up. By embracing this distinction, implementation research can temper overly optimistic assumptions, better reflect real-world constraints, and contribute more meaningfully to evidence-based practice. We argue that making this distinction explicit is a necessary step toward a more pragmatic and transparent science of implementation.
在干预研究中,疗效(理想条件下的表现)与效果(实际环境中的表现)之间的区别已得到充分确立。干预效果通常被用作实施准备情况的替代指标。然而,如果没有充分考虑常规实践环境的复杂性,依赖这一假设可能会导致对实际结果的过度乐观预期。
本文介绍了实施疗效(在受控或高度支持条件下的实施策略表现)与实施效果(在典型的、资源受限环境下的表现)之间的区别。我们认为,疗效 - 效果的区别对于实施研究而言与干预研究同样关键。认识并系统地运用这一区别能够提高概念清晰度、强化研究设计,并增强研究结果在实际应用中的相关性和可推广性。然而,尽管其重要性,这一区别在实施研究中却很少被明确阐述。研究往往未能明确调查实施策略所依据的条件;各项研究在反映常规实践的程度上差异很大。使这个问题更加复杂的是,经济评估在实施研究中仍然不常见。然而,如果没有对资源使用进行系统评估,就很难确定所报告的实施结果是通过符合实际情况的可行策略实现的,还是通过诸如专门人员配备、外部协助或经济激励等密集支持实现的,而这些在日常实践中很少具备。为了填补这一空白,我们建议将来自临床试验的PRECIS - 2(实用解释性连续体指标总结2)框架改编为一个“实施PRECIS”工具。针对实施研究改编后的PRECIS - 2版本可以提供一种系统的方法来描述一项研究在多大程度上反映了理想化条件与实际实践。
明确实施策略是在类似疗效还是类似效果的条件下进行研究,能够加强研究设计、解释以及与利益相关者的沟通。它还支持关于复制和扩大规模的明智决策。通过接受这一区别,实施研究可以缓和过度乐观的假设,更好地反映实际限制,并更有意义地为循证实践做出贡献。我们认为明确这一区别是迈向更务实、更透明的实施科学的必要步骤。